Guoqiang Zhang
Johnson & Johnson (United States)(US)Zhoushan Hospital(CN)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Organic Electronics and Photovoltaics, MicroRNA in disease regulation, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma(2018)35 cited
- → CDK5 destabilizes PD-L1 via chaperon-mediated autophagy to control cancer immune surveillance in hepatocellular carcinoma(2023)28 cited
- → Synthesis, characterization and comparative photovoltaic behavior of diketopyrrolopyrrole (DPP)-containing poly(phenylene vinylene)s varying at N-alkyl or 3,6-aryl substituents in DPP units(2010)19 cited
- → Kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19: a descriptive study(2020)7 cited
- → Suppression of SLC39A6‐CREB1 axis in liver cancer causes PCK1‐mediated mitochondrial dysfunction(2023)6 cited
- Combined use of choledochoscope and duodenoscope in treatment of bile peritonitis after removal of T-tube.(2006)
- → Pre-radiofrequency ablation MRI imaging features predict the local tumor progression in hepatocellular carcinoma(2020)6 cited
- → Expert consensus on emergency procedures for portal hypertension bleeding (2022)(2023)5 cited
- → P-077 Prophylactic Tocilizumab to Mitigate Cytokine Release Syndrome in Patients Receiving Talquetamab for Relapsed/Refractory Multiple Myeloma: Results From the Phase 1/2 MonumenTAL-1 Study(2024)5 cited
- → Blood manganese and non-alcoholic fatty liver disease in a high manganese exposure area in China(2023)5 cited